Therapeutic Goods Committee (TGC)
An appointment process for TGC is currently underway. Membership details will be published as soon as they are available.
The Therapeutic Goods Committee (TGC) is established under regulation 34 of the Therapeutic Goods Regulations 1990 (the regulations) to provide advice and to make recommendations to the Minister for Health on the adoption of standards for therapeutic goods, matters relating to standards for therapeutic goods, including requirements for labelling and packaging and standards for manufacture of therapeutic goods, and matters relating to medical device standards, conformity assessment standards and standards for biologicals.
For further details on the role and operation of the TGC, refer to the Therapeutic Goods Regulations 1990.
The TGC currently has one subcommittee.
This Subcommittee was established in 2008 to advise the TGC on standards for adoption in relation to the safety and quality of therapeutic goods that are human blood and blood components, blood products, human tissues, progenitor cells, cellular therapies and other products designated as biologicals, or any other matter referred to it by the Secretary.
TGC planned meeting dates 2014
|Meeting no.||Meeting date|
|40||20 June 2014|
To contact the TGC Secretary:
|Phone||+61 2 6232 8623|
|Postal address||The Secretary
Therapeutic Goods Committee
Therapeutic Goods Administration
PO Box 100
Woden ACT 2606